You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Analyzed data from a double-blinded RCT involving 485 dyslipidemia patients to assess Choletrapib’s impact on HDL cholesterol. Examined HDL levels at baseline, 1 year, and 2 years using ANCOVA. Observed a significant increase in HDL cholesterol in the treatment group compared to the control.